Skip to main content
Communications Biology logoLink to Communications Biology
. 2021 Nov 15;4:1310. doi: 10.1038/s42003-021-02832-5

Author Correction: Cryo-EM structures of inhibitory antibodies complexed with arginase 1 provide insight into mechanism of action

Rachel L Palte 1,, Veronica Juan 2, Yacob Gomez-Llorente 3, Marc Andre Bailly 2, Kalyan Chakravarthy 4,8, Xun Chen 3, Daniel Cipriano 2, Ghassan N Fayad 5, Laurence Fayadat-Dilman 2, Symon Gathiaka 1, Heiko Greb 2,9, Brian Hall 6, Mas Handa 2, Mark Hsieh 2, Esther Kofman 2, Heping Lin 6, J Richard Miller 4, Nhung Nguyen 2, Jennifer O’Neil 7,10, Hussam Shaheen 6,11, Eric Sterner 6, Corey Strickland 3, Angie Sun 6, Shane Taremi 6, Giovanna Scapin 3,12
PMCID: PMC8593008  PMID: 34782734

Correction to: Communications Biology 10.1038/s42003-021-02444-z, published online 29 July 2021.

In this article, the author Ghassan N. Fayad was inadvertently omitted from the author list. All authors agree with amending the author list. The author and affiliation lists have been updated to the following, with new additions shown in bold font:

*Rachel L. Palte1, Veronica Juan2, Yacob Gomez-Llorente3, Marc Andre Bailly2, Kalyan Chakravarthy4,8, Xun Chen3, Daniel Cipriano2, Ghassan N. Fayad5, Laurence Fayadat-Dilman2, Symon Gathiaka1, Heiko Greb2,9, Brian Hall6, Mas Handa2, Mark Hsieh2, Esther Kofman2, Heping Lin6, J. Richard Miller4, Nhung Nguyen2, Jennifer O’Neil7,10, Hussam Shaheen6,11, Eric Sterner6, Corey Strickland3, Angie Sun6, Shane Taremi6, Giovanna Scapin3,12

Affiliations

1Department of Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA

2Department of Discovery Biologics, Merck & Co., Inc., South San Francisco, CA, USA

3Department of Discovery Chemistry, Merck & Co., Inc., Kenilworth, NJ, USA

4Department of Discovery Biology, Merck & Co., Inc., Boston, MA, USA

5 Department of Preclinical Development, Merck & Co., Inc. Boston, MA, USA

6Department of Discovery Biologics, Merck & Co., Inc., Boston, MA, USA

7Department of Discovery Oncology, Merck & Co., Inc., Boston, MA, USA

8Present address: Ipsen Bioscience Inc., Cambridge, MA, USA

9Present address: Synthekine Inc., Menlo Park, CA, USA

10Present address: Xilio Therapeutics, Waltham, MA, USA

11Present address: Pandion Therapeutics, Cambridge, MA, USA

12Present address: NanoImaging Services, Woburn, MA, USA

*corresponding author (rachel.kubiak@merck.com)

In addition, the Author Contributions section has been updated to include contributions from Ghassan N. Fayad, shown in bold font here:

R.L.P, Y.G.-L., S.G., C.S., G.S. and G.N.F contributed to the acquisition, analysis, or interpretation of the structural data. V.J., M.A.B., L.F.-D., M. Handa, E.K., X.C., J.R.M., N.N., J.O., H.S., K.C., S.T., D.C., M. Hsieh, and H.G. contributed to the acquisition, analysis or interpretation of the biological and biophysical data. V.J., L.F.-D., B.H., M. Handa, E.S., A.S., H.L., S.T. and H.S. contributed to or directed the design and production of protein and/or antibodies. All authors critically reviewed or revised the paper for the intellectual content and approved the final version.

The errors have been corrected in the HTML and PDF versions of the article.


Articles from Communications Biology are provided here courtesy of Nature Publishing Group

RESOURCES